Denali Therapeutics (DNLI) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order by the CEO, with introductions of directors and management in attendance, and confirmation of a virtual format for broader access.

• Attendance was confirmed as by invitation only, with registration required, and the list of eligible stockholders was certified and made available.

• The agenda included electing three Class III directors, ratifying the appointment of the independent auditor, and an advisory vote on executive compensation.

Corporate governance

• The Inspector of Election was appointed and sworn in, and a quorum was confirmed as present.

• Voting procedures were explained, with each share entitled to one vote, and instructions provided for proxy and ballot voting.

Board and executive committee updates

• Three current directors were nominated for re-election as Class III directors, with the board unanimously recommending their election.